Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
Clinical trial NCT07063225 · RECRUITING
Trial details
- NCT number
- NCT07063225
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.